Hyperlipidemia or Mixed Dyslipidemia at High Risk for Cardiovascular Events
1 clinical trials · Condition
◉ Watch Hyperlipidemia or Mixed Dyslipidemia at High Risk for Cardiovascular Events
| Record | Firm | Date |
|---|---|---|
| Study of Low-Density Lipoprotein Cholesterol (LDL-C) Reduction Using Evolocumab (AMG 145) in Japanese Patients With Advanced Cardiovascular Risk (NCT01953328) | Amgen | 2013-10-01 |
Track Hyperlipidemia or Mixed Dyslipidemia at High Risk for Cardiovascular Events automatically
Every clearance here is in the API, with alerts when new ones post.